Matrix metalloproteinases and cellular fibrinolytic activity
about
sameAs
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expressionLuteolin Inhibits the Activity, Secretion and Gene Expression of MMP-3 in Cultured Articular Chondrocytes and Production of MMP-3 in the Rat KneeInterferon-γ protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia.Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae.Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cellsRegulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.Protein changes in the retina following experimental retinal detachment in rabbits.Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo.Enhanced fibrinolysis in fingerstick blood samples: a possible role for matrix metalloproteinase-9.Molecular mechanism of the inhibition effect of Celecoxib on corneal collagen degradation in three dimensions.Effects of prunetin on the proteolytic activity, secretion and gene expression of MMP-3 in vitro and production of MMP-3 in vivoMolecular mechanism of the inhibition effect of Lipoxin A4 on corneal dissolving pathology processApigenin Regulates Interleukin-1β-Induced Production of Matrix Metalloproteinase Both in the Knee Joint of Rat and in Primary Cultured Articular Chondrocytes.Thrombosis recanalization by paeoniflorin through the upregulation of urokinase‑type plasminogen activator via the MAPK signaling pathway.The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.Betulin suppressed interleukin-1β-induced gene expression, secretion and proteolytic activity of matrix metalloproteinase in cultured articular chondrocytes and production of matrix metalloproteinase in the knee joint of ratEffect of oleanolic acid on the activity, secretion and gene expression of matrix metalloproteinase-3 in articular chondrocytes in vitro and the production of matrix metalloproteinase-3 in vivoHost matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?Interaction of spirochetes with the host fibrinolytic system and potential roles in pathogenesis.Baekjeolyusin-tang and its active component berberine block the release of collagen and proteoglycan from IL-1β-stimulated rabbit cartilage and down-regulate matrix metalloproteinases in rabbit chondrocytes.A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.Moringa oleifera Lam.: Protease activity against blood coagulation cascade.Complex Regulation of the Pericellular Proteolytic Microenvironment during Tumor Progression and Wound Repair: Functional Interactions between the Serine Protease and Matrix Metalloproteinase Cascades.PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1.Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage.Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication.Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.NFATc3 promotes Ca(2+) -dependent MMP3 expression in astroglial cells.Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.Priming the seed: alters epithelial cell invasiveness in early gastric carcinogenesis
P2860
Q33287995-83684F3E-965A-4B43-8E02-729311300BF3Q33552842-299ADBE3-3D86-44FC-98E9-E667A96AB62FQ33765076-96298CEE-2B81-493A-8765-34FA7F4638EBQ34300423-A3FF1FE1-AC6B-49F0-9B8A-633BC9FF2121Q34494535-A5A5CA21-A2D8-461F-A7D0-BFE1262D67C2Q34674982-3FEEE1C5-A6FA-4ECE-B88A-DA6D5702E503Q34975562-9BB4AC09-3C2F-44A2-A7B4-246DE2BEC659Q35112020-F337FE88-906A-4927-85A2-97B5D83DE809Q35142158-C806A3CF-3C33-48F8-82EA-CAF357C21F9AQ35146507-F71347DB-5126-4136-A164-8902190A02E6Q35531768-C33F2FC0-E8F1-4F76-BDEB-18007F8B6421Q36015710-C79F1AF7-BC7C-4210-839C-AEE6589747FFQ36016438-1FF1B7E5-7B46-4C74-AA7F-C5574FE885EEQ36192121-33687CAD-2FEB-4C4D-993A-12369D94EB11Q36627632-7DF00D85-9F6D-4D48-8B45-E36A7786F914Q36632435-69BEAE21-C731-440D-9C07-FB411030B8E1Q36640418-4D50C4D9-21F2-4252-90C8-5B9B2C164F43Q36931196-AC78E8E1-9A88-4365-B9AB-DF763DE8011EQ36997866-A295D53D-730C-451C-8F24-64B5766E7D0FQ37030520-F3A09FBE-E2C2-4B76-A0A4-794A4EC68DEBQ37443132-8CD73DE6-AB33-4647-8919-54540B924786Q37559563-E26A43FD-1297-4BA9-9EFF-5B8F83000FAAQ37689511-ABACFB0B-FC64-4455-8DB1-F2AF25CB61AFQ38182192-9BEC390F-D51B-456B-873F-83F45ED9CE66Q38443764-32828FA2-AB35-47C1-A1C1-2C3F2918C826Q38479557-EEBD2AE0-31D5-40E0-A472-488F0EA66093Q39993979-B1B7DB61-6A7C-4CA2-AE8E-8875DD336ED4Q40116192-6FE6D677-EB4A-4BBA-A7D3-53EBAD449843Q41808886-99D54A9E-6F8F-4594-9AF9-BA2C50CC5275Q41857137-88F96B0F-269F-4626-8953-A85DC1D671F7Q42399810-5BF68B5A-691A-4DC7-899E-887DF00C696DQ44135936-EF9517E6-2595-4722-BB2E-4CD8E2FB5015Q44957077-508BE973-ACA8-453F-85C1-6C85241B5BDAQ47165301-35604856-3ED6-4E81-9945-F8915AE1D006Q47376040-F5EBE9BB-0850-4570-BCA4-A7E8C0D7FD7CQ50067582-68B42D5E-18AF-4860-8448-AC27ACFE1E23Q51033680-C1FB824D-4100-4D36-AB5F-D2220405909EQ51375703-71BE2646-C9D3-4AFE-91B5-364F2BC6CD89Q58737385-77B41231-647D-4381-BD0B-16A73C56B18A
P2860
Matrix metalloproteinases and cellular fibrinolytic activity
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2002)
@en
vedecký článok (publikovaný 2002-01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
Matrix metalloproteinases and cellular fibrinolytic activity
@ast
Matrix metalloproteinases and cellular fibrinolytic activity
@en
Matrix metalloproteinases and cellular fibrinolytic activity
@nl
type
label
Matrix metalloproteinases and cellular fibrinolytic activity
@ast
Matrix metalloproteinases and cellular fibrinolytic activity
@en
Matrix metalloproteinases and cellular fibrinolytic activity
@nl
prefLabel
Matrix metalloproteinases and cellular fibrinolytic activity
@ast
Matrix metalloproteinases and cellular fibrinolytic activity
@en
Matrix metalloproteinases and cellular fibrinolytic activity
@nl
P3181
P356
P1433
P1476
Matrix metalloproteinases and cellular fibrinolytic activity
@en
P2093
H Roger Lijnen
P2888
P3181
P356
10.1023/A:1013908332232
P407
P577
2002-01-01T00:00:00Z
P6179
1036498511